All articles tagged with #oppenheimer
NVDA is expected to see a typical $2–3 billion upside to Q4 FY26 and Q1 FY27 sales, supporting a Buy rating and a $265 price target (roughly 40% upside). The company is projected to post about $65.6 billion in Q4 revenue and $1.52 EPS as AI demand accelerates, GB300 Ultra drives growth, and cloud capex rises; with China now included, Nvidia’s total addressable market could approach $4 trillion, underscoring its leadership in AI platforms.
Adobe stock fell after Oppenheimer downgraded the company, signaling a cautionary near‑term outlook and prompting investors to rethink its growth prospects.
Emily Blunt discusses her role in 'The Smashing Machine' and its connection to her work on 'Oppenheimer,' highlighting a serendipitous encounter that brought the project together and her deep involvement in the performance.
Christopher Nolan has been elected president of the Directors Guild of America, succeeding Lesli Linka Glatter, as the union prepares for upcoming TV and film contract negotiations, with a focus on safety issues and expanding residuals for foreign streaming.
The article reflects on the history and ongoing dangers of nuclear weapons, highlighting the ethical dilemmas faced by scientists like Oppenheimer during the Manhattan Project, the lack of dissent at Los Alamos, and the current global arms race, emphasizing the need for renewed responsibility and disarmament efforts.
Oppenheimer's chief investment strategist, John Stoltzfus, predicts continued market growth into 2025, with the S&P 500 potentially reaching 7100. The firm highlights two 'Strong Buy' stocks with significant growth potential: Sagimet Biosciences and Y-mAbs Therapeutics. Sagimet is advancing its fatty acid synthase inhibitors for conditions like MASH and acne, while Y-mAbs is developing its SADA platform for targeted cancer therapies. Both companies have received positive analyst ratings, with Sagimet potentially seeing a 583% increase and Y-mAbs a 144% rise.
Oppenheimer Asset Management's Chief Investment Strategist, John Stoltzfus, predicts the S&P 500 will reach 7,100 by the end of next year, driven by a strong economy and advancements in artificial intelligence. This forecast is the most bullish among peers, suggesting a 17% upside from the current level. Stoltzfus believes the rally will continue across various sectors, supported by economic growth, interest rate cuts, and improved earnings. His outlook aligns with a few other optimistic strategists, contrasting with more conservative forecasts from firms like Morgan Stanley and Goldman Sachs.
Emma Dumont, known for her role in 'Oppenheimer,' has come out as trans masculine non-binary, adopting the name Nick for personal use while retaining Emma Dumont professionally. The announcement has sparked mixed reactions on social media. Dumont's revelation follows similar announcements by other celebrities, such as Elliot Page.
Actor Emma Dumont, known for their role in "Oppenheimer," has publicly embraced their identity as a transmasculine nonbinary person, adopting the name Nick in their personal life while retaining Emma Dumont professionally. They updated their pronouns to "they/them" on Instagram, receiving supportive comments from fans. Dumont's publicist confirmed the identity update, explaining the decision to maintain their professional name. This announcement aligns with a broader trend of public figures sharing their gender identities.
Nick Dumont, known for their role in the film Oppenheimer, has publicly come out as transmasculine and non-binary, updating their pronouns to "they/them" on social media. Dumont's announcement was met with support from fans, celebrating their openness and identity. The actor joins other celebrities who have come out as LGBTQ+ in 2024. Dumont gained recognition for their performance in the Oscar-winning film Oppenheimer, which also saw significant success at the BAFTAs.
Emma Dumont, known for their role in "Oppenheimer," has come out as non-binary and now goes by the name Nick Dumont, using "they/them" pronouns. While their professional name remains Emma Dumont, they will use Nick in personal settings. This announcement was made via Instagram, and their representative confirmed the news, describing Nick as a trans masculine non-binary person. Nick's career includes roles in "Licorice Pizza" and "The Gifted," with upcoming projects like "The New Me."
Emily Blunt hinted at the possibility of a sequel to 'The Devil Wears Prada' during the Red Sea Film Festival, expressing enthusiasm about reuniting with Meryl Streep and Stanley Tucci. She praised the unique musical film 'Emilia Pérez' and shared her joyful experience during the awards season for 'Oppenheimer.' Blunt also discussed her role in the upcoming film 'The Smashing Machine,' where Dwayne Johnson stars as MMA fighter Mark Kerr.
Robert Pattinson is set to reunite with director Christopher Nolan for a new project at Universal Pictures, joining a star-studded cast including Matt Damon, Tom Holland, and Zendaya. This follows their previous collaboration on "Tenet." The film is expected to begin production in early 2025, with a release date set for July 17, 2026. Meanwhile, Pattinson is also involved in several other projects, including a sequel to "The Batman" and Bong Joon-Ho's "Mickey 17."
Robert Pattinson is set to reunite with director Christopher Nolan for a new, highly secretive film project, which will be released by Universal Pictures in 2026. The film, which has yet to reveal its plot, will also feature a star-studded cast including Matt Damon, Tom Holland, Anne Hathaway, Lupita Nyong’o, and Zendaya. This marks Pattinson's second collaboration with Nolan, following their work on the 2020 film 'Tenet.' The project is being produced by Nolan and his wife Emma Thomas under their Syncopy banner, with filming expected to begin in early 2025.
Dwayne Johnson was inspired by watching 'Oppenheimer' in Imax to ensure his Christmas action film 'Red One' could also be experienced in the premium format. Despite this ambition, 'Red One' has not achieved the same success, with a disappointing international box office performance and critical reviews. The film, directed by Jake Kasdan, is set to open in U.S. theaters on November 15.